19 Dec, 2022 FDA Denies Requests for Revocation of EUA for Covid Vaccine for Use in Individuals 5-11 and 12-17 Years of Age By Melissa Gilmore Jarred Reiling Keo Shaw The FDA has denied two citizen petitions filed on behalf of the Informed Consent Action Network (ICAN) requesting the agency revoke its...
08 Dec, 2022 Poland - Life Sciences Monthly Brief, November 2022 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less We first wrote about the planned amendments to the Pharmaceutical Law and certain other acts (the so-called Verticalisation Act) in...
01 Dec, 2022 FDA publishes draft guidance on active ingredient sameness in proposed generic drugs and their reference listed drugs By Christine Lentz The FDA recently published “Sameness Evaluations in an ANDA – Active Ingredients,” a new draft guidance detailing recommendations for...
21 Nov, 2022 Inspiring Women in the Life Sciences Industry: what we can learn from them By Lyndsey Hudson As someone who believes strongly in empowering women in the workplace and building a diverse and inclusive culture, I really enjoyed...
17 Nov, 2022 Global Life Sciences Supply Chain Insights - At the Intersection of Science and Law Podcast Series By Lauren Murzda Richard Taylor Published in Chambers Expert Focus US partner Lauren Murdza and UK partner Richard Taylor share their insights on supply chain issues in...
15 Nov, 2022 Clinical Trials and Privacy Matters: A Cross-border Guide By Marco de Morpurgo This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
14 Nov, 2022 Thaler Shut Down: High Court of Australia confirms AI incapable of being an "inventor" By Nicholas Tyacke Robynne Sanders Greg Bodulovic Alexandra de Zwart Sarah McKenzie Jordan Davis +3 more... Show less Artificial intelligence (AI) is playing an increasingly relevant and important role in our lives. Be it through your personal devices,...
10 Nov, 2022 SPACs targeting Latin America-based life sciences and healthtech companies By Bruna Rocha Juliana Marcondes The SPAC structure not only enables the target companies to be listed in the United States’ public stock market through a simpler and...
08 Nov, 2022 California strengthens protections for mental health information exchanged through digital health applications By Andrew Serwin Kristi Kung Bethany Hills With the mounting mental health crisis intensified by the COVID-19 pandemic, the telemental health industry has exploded in recent years....
28 Oct, 2022 Considering Modifications to Existing FDA Regulatory Incentives to Achieve Greater Racial and Ethnic Diversity in Clinical Trials for Drug Approvals By Kirsten Axelsen When clinical trials for new drug approvals fail to adequately represent racial and ethnic groups, there is a lost opportunity to collect...
25 Oct, 2022 Your clinical decision support software may now be regulated by FDA as a medical device: 4 key takeaways from FDA’s webinar on the Final CDS Guidance By Keo Shaw Bethany Hills Danny Tobey In the wake of FDA’s long-awaited final guidance for the regulation of Clinical Decision Support Software, many software developers and...
21 Oct, 2022 Advocate General against a stricter standard of proof of harm in merger cases By Joost Haans Yesterday (20 October 2022), Advocate General (AG) Kokott of the European Court of Justice issued her Opinion in relation to the appeal...
20 Oct, 2022 The potential for unintended consequences in the Inflation Reduction Act By Jim Greenwood Alex Pinson Jamie Gregorian The Inflation Reduction Act (IRA) significantly impacts the US economic model for prescription drug innovation through the imposition of...
19 Oct, 2022 EU Pharma & Medical Device Regulation 2023 By Marco de Morpurgo Nicola Landolfi Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
12 Oct, 2022 The latest legislative changes in the pharmaceutical industry in Poland By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Urszula Grębowska In our latest report, we provide an update on the key legislative changes proposed and introduced in the pharmaceutical sector in Poland.
10 Oct, 2022 Organoids: science fiction or the future of pre-clinical studies? By Marion Abecassis Ruth Faragher New technologies based on human cells are increasingly seen as key to reducing the time and cost in bringing drugs to market. This is an...